Glauco Liquid
NDC Package 55714-4810-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Glauco (aconitum napellus, aurum metallicum, belladonna, causticum, cinchona officinalis, colchicum autumnale, euphrasia officinalis, gelsemium sempervirens, nux vomica, osmium metallicum, phosphorus, physostigma venenosum, rhus toxicodendron, spigelia anthelmia.) liquids is formulated for symptoms such as blurred vision and red eyes. This formulation utilizes a liquid delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-4810.

Identification & Billing

NDC Package Code
55714-4810-1
Package Description
30 mL in 1 BOTTLE, GLASS
Product Code
55714-4810
11-Digit Billing Format
55714481001

Clinical Specifications

Proprietary Name
Glauco
Non-Proprietary Name
Aconitum Napellus, Aurum Metallicum, Belladonna, Causticum, Cinchona Officinalis, Colchicum Autumnale, Euphrasia Officinalis, Gelsemium Sempervirens, Nux Vomica, Osmium Metallicum, Phosphorus, Physostigma Venenosum, Rhus Toxicodendron, Spigelia Anthelmia.
Substance Name
Aconitum Napellus; Atropa Belladonna; Causticum; Cinchona Officinalis Bark; Colchicum Autumnale Bulb; Euphrasia Stricta; Gelsemium Sempervirens Root; Gold; Osmium; Phosphorus; Physostigma Venenosum Seed; Spigelia Anthelmia; Strychnos Nux-vomica Seed; Toxicodendron Pubescens Leaf
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Formulated for symptoms such as blurred vision and red eyes..

Regulatory & Marketing

Labeler Name
Newton Laboratories, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
09-02-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55714-4810-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of Glauco, a human over the counter drug labeled by Newton Laboratories, Inc.. This liquid is formulated for oral use and contains aconitum napellus; atropa belladonna; causticum; cinchona officinalis bark; colchicum autumnale bulb; euphrasia stricta; gelsemium sempervirens root; gold; osmium; phosphorus; physostigma venenosum seed; spigelia anthelmia; strychnos nux-vomica seed; toxicodendron pubescens leaf as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on September 02, 2019. The current certification is valid through December 31, 2026.

How is this Newton Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714481001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55714-4810-1
11-Digit CMS (5-4-2)
55714-4810-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.